Top ten highlights from the APAC PE, VC, and startup ecosystem this week:
- Southeast Asian Startups Raise a Whopping $1.78 Billion in July
– The largest influx of funding in 11 months. - India and Greater China Face Uncertain Future as Startup Investments Drop
– India hits a three-year low of $564 million, while Greater China experiences a 13.1% drop at $4.2 billion. - US President Joe Biden Signs Executive Order to Restrict US Investments in China’s Sensitive Tech
– Move likely to escalate tensions between the world’s two largest economies. - Singapore-based Endowus Secures $35 Million in Funding Round
– Wealth management platform receives investments from Citi Ventures, MUFG Innovation Partners, and others. - Blue Planet Environmental Solutions Receives Undisclosed Investment from Bintang Capital Partners
– Waste management solutions company based in Singapore secures funding. - FOMO Group Acquires CapBridge and 1exchange in Singapore
– Singapore-based fintech firm expands its portfolio with the acquisition of two local companies. - Lamudi Indonesia Seeks Acquisitions to Support Profitability
– Property listing platform actively looking for acquisition opportunities. - Allozymes, a Singapore-based Startup, Secures Series A Funding
– Deep tech startup raises capital from investors including Xora Innovation and Seventure Partners. - BondbloX Raises Up to $10 Million in a Series B2 Funding Round
– Singapore-based fintech company raises capital for its Bond Exchange. - Baskit’s Double-Digit Funding Round Led by MDI Ventures
– Indonesian B2B commerce company secures funding to strengthen its position in the supply chain business.These groundbreaking investments and acquisitions in the Asian startup ecosystem showcase the growing potential and interest in the region. Stay tuned for more updates in the world of startup funding!
APAC Private Markets Research
Explore latest Insights on APAC Private Markets on Smartkarma
Disclaimer:This article by is general in nature and based on publicly available information and not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material. While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
Also, check out the latest in ECM Research on Smartkarma
